Navigation Links
Hospira Receives TGA Approval for Nivestim™, Australia's First Biosimilar Filgrastim
Date:9/26/2010

f FN, and was as well tolerated, with a similar adverse event profile.(2)

Nivestim is Hospira's second biosimilar and first in Australia. The company's biosimilar erythropoietin, Retacrit™, is currently available in 17 European countries, and Nivestim was approved by the European Commission in June 2010.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 13,500 employees. The head office for Hospira in the Asia Pacific region is in Melbourne, Australia. Learn more at www.hospira.com.

Private Securities Litigation Reform Act of 1995 --

A Caution Concerning Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding Hospira's goals with respect to Nivestim. Hospira cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Economic, competitive, governmental, legal, technological and other factors that may affect Hospira's operations and may cause actual results to be materially different from expectations include the risks, uncertainties and factors discussed under the headings "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Hospira's
'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Hospira Japan Receives Approval for New Indication for Precedex IV™ 200ug
2. Hospira Announces CEO Succession Plan
3. Hospira to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference Aug. 12
4. Hospira Begins Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
5. Hospira TheraDoc(TM) Infection Control Assistant(TM) Documents Interventions to Help Hospital Reduce Catheter-Related Infections
6. Hospira Announces Intention to Complete Tender Offer for Shares of Javelin Pharmaceuticals
7. Hospira Receives FDA Approval for Meropenem for Injection, USP (I.V.)
8. Hospira Announces Further Extension of Tender Offer for Shares of Javelin Pharmaceuticals
9. Hospira to Standardize Intravenous (I.V.) Administration Sets Portfolio to Non-DEHP
10. Hospira Highlights a Year of Significant Progress at Its 2010 Annual Meeting of Shareholders
11. Hospira to Present at Citi 2010 Global Health Care Conference May 27, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 2013 /PRNewswire-iReach/ -- Today at American Society for ... Ginocchio discussed Specific Technologies blood culture ... of microorganisms producing bloodstream infection. Dr. Ginocchio is ... Division of Infectious Disease Diagnostics at North Shore-LIJ ... health system. (Photo: http://photos.prnewswire.com/prnh/20130520/CG16829 ) ...
(Date:5/20/2013)... Calif. , May 20, 2013 /PRNewswire-iReach/ -- ... of the first study demonstrating detection of pathogenic ... Yersinia pestis and Bacillus anthracis ... and Prevention,s list of potential bio-threats. This seminal ... and Technology Laboratory, Salisbury ...
(Date:5/20/2013)... , May 20, 2013  Hill-Rom Holdings, Inc. (NYSE: ... a management presentation at the 38 th Annual ... on May 30, 2013, at 1:30 p.m. ... You are invited to listen to the live ... or access it directly at http://www.media-server.com/m/p/f7bj3q84 . A ...
Breaking Medicine Technology:Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 3Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria 2
... 7, 2011 Rochester Medical Corporation (NASDAQ: ... the previously announced purchase of Laprolan B.V., the former ... BioSciences N.V. Under the terms of the purchase agreement ...  For more information regarding this transaction please refer to ...
... April 7, 2011 Ascension Orthopedics, Inc., a world ... the TITAN Modular Total Shoulder.  The surgeries were performed ... Baltimore, MD.     "I have been ... of years in my practice. Now that Ascension has ...
Cached Medicine Technology:Ascension Orthopedics Announces TITAN™ Modular Shoulder Implantations at Union Memorial Hospital 2
(Date:5/20/2013)... In celebration of National Women’s Health Week ... at The Feinstein Institute for Medical Research ... Women in Science and Medicine (AWSM) , hosted its ... educators, business and community leaders from the region attended ... in science. , “Women face unique barriers to ...
(Date:5/20/2013)... Philadelphia, Pa. (May 20, 2013) Posterior fossa subdural ... newborns, generally occurring after difficult deliveries. But with appropriate ... even in severe cases of PFSDH, reports a study ... , official journal of the Congress of Neurological ... Williams & Wilkins , a part of Wolters ...
(Date:5/20/2013)... the U.S. health care system, accounting for a rising ... advanced diagnostic center for primary care physicians, according to ... as the most expensive place to get medical care, ... who cannot get care elsewhere and may play a ... according to the study. , Emergency departments are now ...
(Date:5/20/2013)... that transforms the sweet flavor of orange juice into ... sensory phenomenon in colorful, animated detail check ... Bytesize Science video series at http://www.BytesizeScience.com ... society, explains that the mainstay ingredients in toothpaste include ... short. When you brush your teeth, SLS produces the ...
(Date:5/20/2013)... schoolers prepare for final exams, teens nationwide may be ... stimulant or amphetamine -- to gain an academic edge. ... one in 100 parents of teens 13-17 years old ... Study drugs refer to stimulant medications typically prescribed for ... prescribed medicines in this category include Adderall, Concerta, Ritalin, ...
Breaking Medicine News(10 mins):Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 3Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 2Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 3Health News:Hospital emergency departments gaining in importance, study finds 2Health News:Hospital emergency departments gaining in importance, study finds 3Health News:1 in 10 teens using 'study drugs,' but parents aren't paying attention 2
... WASHINGTON, May 28 A study released today in ... requiring all to show proof of health insurance has ... President Obama,s promised "public option" to private insurance must ... Watchdog. Consumer Watchdog said that Massachusetts, experience shows that ...
... changing the environment for communicating health information. In a ... University of Missouri researchers examine how the digital media ... United States. Effective health communication can significantly enhance health ... in people,s access to health information and services, according ...
... Recognize Medical Devices in Independent CategoryNEW YORK, May 28 ... pharmaceutical research and development, has added a new recognition category ... for the 2009 Prix Galien USA are now being accepted ... through Wednesday, July 1, 2009. For the first time, the ...
... Pa., May 28 In a demonstration of ... and creating jobs in Pennsylvania, Department of Environmental ... completion of the new energy service center at ... marked a milestone in Susquehanna Health,s Project 2012, ...
... studies address donor factors that could affect outcomes for ... (HCV). One found that donor steatosis, or fat in ... three-year survival in recipients with or without HCV. However, ... did adversely affect the outcomes of HCV-positive recipients more ...
... Fla., May 28 "Financially distressed employees have ... hurting their physical health as well as taking ... says Dr. E. Thomas Garman, president, Personal Finance ... impacts emotional health. One-third of school, hospital, and ...
Cached Medicine News:Health News:Health Affairs Report On Mass. Mandatory Insurance Law Confirms: Strong Public Option Must Be Included in National Health Reform 2Health News:Health Affairs Report On Mass. Mandatory Insurance Law Confirms: Strong Public Option Must Be Included in National Health Reform 3Health News:MU researchers offer insights for advancing health communication through digital media 2Health News:Prix Galien USA Now Accepting Nominations for Premiere Biopharmaceutical Industry Award 2Health News:Economic Stimulus Funding Will Help Increase Energy Efficiency of Williamsport Hospital 2Health News:Some donor factors affect outcomes for HCV-positive liver transplant recipients 2Health News:Financial Distress Taking Toll on Employee Health 2
... The innovative E.coli ... Pro-Lab offers definitive identification ... the use of a ... the possibility of cross-reactions ...
A single tube that performs two rapid tests for E. coli from culture. ColiScreen™ combines both the indole test with the glucuronidase test to increase the specificity....
The Oxoid Legionella Latex Test is a latex agglutination test for the identification of predominant Legionella species grown on plate media from patients with suspected Legionellosis or from environm...
Inquire...
Medicine Products: